Published in J Bacteriol on December 01, 1990
Genetic map of Salmonella typhimurium, edition VIII. Microbiol Rev (1995) 3.87
A ribosomal ambiguity mutation in the 530 loop of E. coli 16S rRNA. Nucleic Acids Res (1992) 1.76
A gripping tale of ribosomal frameshifting: extragenic suppressors of frameshift mutations spotlight P-site realignment. Microbiol Mol Biol Rev (2009) 1.50
The growth defect in Escherichia coli deficient in peptidyl-tRNA hydrolase is due to starvation for Lys-tRNA(Lys). EMBO J (1996) 1.36
Selection for loss of tetracycline resistance by Escherichia coli. J Bacteriol (1981) 11.83
Linkage map of Salmonella typhimurium, Edition VI. Microbiol Rev (1983) 6.33
The nucleotide sequence of pACYC184. Nucleic Acids Res (1988) 6.24
Lac repressor can be fused to beta-galactosidase. Nature (1974) 5.84
Slippery runs, shifty stops, backward steps, and forward hops: -2, -1, +1, +2, +5, and +6 ribosomal frameshifting. Cold Spring Harb Symp Quant Biol (1987) 3.72
Characterization of three proteins involved in polypeptide chain termination. Cold Spring Harb Symp Quant Biol (1969) 2.84
Mutant 16S ribosomal RNA: a codon-specific translational suppressor. Proc Natl Acad Sci U S A (1988) 2.26
Genetic screen for cloned release factor genes. J Bacteriol (1984) 2.09
The signal for the termination of protein synthesis in procaryotes. Nucleic Acids Res (1990) 2.05
Mutations in elongation factor EF-1 alpha affect the frequency of frameshifting and amino acid misincorporation in Saccharomyces cerevisiae. Genetics (1988) 1.86
Correlation of nonsense sites in the lacI gene with specific codons in the nucleotide sequence. Nature (1978) 1.60
The nucleotide sequence of the first externally suppressible--1 frameshift mutant, and of some nearby leaky frameshift mutants. EMBO J (1983) 1.52
tRNA hopping: enhancement by an expanded anticodon. EMBO J (1989) 1.47
Nucleotide sequence of trpE of Salmonella typhimurium and its homology with the corresponding sequence of Escherichia coli. J Mol Biol (1982) 1.41
Chromosomal location and structure of the operon encoding peptide-chain-release factor 2 of Escherichia coli. Proc Natl Acad Sci U S A (1988) 1.41
Mutants of elongation factor Tu promote ribosomal frameshifting and nonsense readthrough. EMBO J (1987) 1.36
UGA and non-triplet suppressor reading of the genetic code. Nature (1974) 1.23
Mutants of Escherichia coli altered in both genes coding for the elongation factor Tu. Proc Natl Acad Sci U S A (1978) 1.22
Mutant EF-Tu increases missense error in vitro. Mol Gen Genet (1986) 1.19
Mutants of the elongation factor EF-Tu, a new class of nonsense suppressors. EMBO J (1985) 1.17
Translational frameshifts induced by mutant species of the polypeptide chain elongation factor Tu of Escherichia coli. J Biol Chem (1989) 1.06
Mutant forms of tufA and tufB independently suppress nonsense mutations. J Mol Biol (1987) 0.95
Suppression of a -1 frameshift mutation by a recessive tRNA suppressor which causes doublet decoding. J Bacteriol (1989) 0.90
Antagonistic effects of mutant elongation factor Tu and ribosomal protein S12 on control of translational accuracy, suppression and cellular growth. Biochimie (1988) 0.88
Release factor competition is equivalent at strong and weakly suppressed nonsense codons. Mol Gen Genet (1988) 0.84
The ribosomal domain of the bacterial release factors. The carboxyl-terminal domain of the dimer of Escherichia coli ribosomal protein L7/L12 located in the body of the ribosome is important for release factor interaction. Eur J Biochem (1990) 0.83
Medical student selection: a tentative attempt to establish a code of practice. Br Med J (1980) 7.21
Lymphocyte transformation in vitro measured by tritiated thymidine uptake. I. Lymphocyte culture techniques. Int Arch Allergy Appl Immunol (1970) 5.67
Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science (2000) 4.48
Virulence of antibiotic-resistant Salmonella typhimurium. Proc Natl Acad Sci U S A (1998) 4.28
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature (1991) 3.86
Consultation length and outcome in two group general practices. J R Coll Gen Pract (1983) 3.76
Brief report: fulminating fat embolism syndrome caused by paradoxical embolism through a patent foramen ovale. N Engl J Med (1993) 3.55
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1996) 3.20
Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol (2001) 2.94
Paper and people: the work of the casualty reception clerk. Sociol Health Illn (1989) 2.54
Prospective analysis of stoma-related complications. Colorectal Dis (2005) 2.35
Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med (1991) 2.34
Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: implications for celiac disease diagnosis during routine endoscopy. Am J Gastroenterol (2001) 2.30
The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med (1997) 2.28
Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (1984) 2.14
Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature (1993) 2.04
RCPE UK consensus statement on diabetes. J R Coll Physicians Edinb (2010) 2.03
Comparison of sevoflurane and propofol with rocuronium for modified rapid-sequence induction of anaesthesia. Anaesthesia (1999) 1.98
Prevalence of celiac disease and its endoscopic markers among patients having routine upper gastrointestinal endoscopy. Am J Gastroenterol (1999) 1.93
Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site. J Mol Biol (2000) 1.78
Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol (1999) 1.77
Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium. Mol Microbiol (1999) 1.75
Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci (1994) 1.74
Fusidic acid-resistant mutants define three regions in elongation factor G of Salmonella typhimurium. Gene (1994) 1.74
Lateral spine radiographs before androgen deprivation treatment detect a high incidence of undiagnosed vertebral fragility fractures in men with advanced prostate cancer. J Urol (2011) 1.72
Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia. Br J Anaesth (1999) 1.69
Head injuries: a study evaluating the impact of the NICE head injury guidelines. Emerg Med J (2005) 1.66
The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood (1998) 1.66
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet (2005) 1.63
Muller's ratchet decreases fitness of a DNA-based microbe. Proc Natl Acad Sci U S A (1996) 1.63
Isolation of Yersinia enterocolitica from milk and a dairy farm in Australia. J Appl Bacteriol (1979) 1.63
Lack of mature B cells in nude mice with X-linked immune deficiency. J Exp Med (1982) 1.52
Increased cholecystectomy rate in the laparoscopic era: a study of the potential causative factors. Surg Endosc (2006) 1.50
Community health monitoring: taking the pulse of America's children. Matern Child Health J (1998) 1.47
Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor. Lancet (1968) 1.46
Activated ras oncogenes in human thyroid cancers. Cancer Res (1988) 1.45
Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology (1994) 1.43
Homologous recombination between the tuf genes of Salmonella typhimurium. J Mol Biol (1996) 1.43
Invasion of neurones in vitro by non immune lymphocytes. An electron microscopic study. Br J Exp Pathol (1968) 1.41
Clinical trial of iron therapy of psychomotor function in anaemic women. Br Med J (1970) 1.41
Low-dose clonidine infusion during labour. Br J Anaesth (1999) 1.40
Use of hyperbaric oxygen in rheumatic diseases: case report and critical analysis. Lupus (1995) 1.39
Benign vaginal polyp: a histological, histochemical and immunohistochemical study of 20 polyps with comparison to normal vaginal subepithelial layer. Histopathology (1992) 1.38
Is midwifery safe in the embrace of the UKCC? Midwives (1995) (1995) 1.38
Sequence heterogeneity and anomalous electrophoretic mobility of kinetoplast minicircle DNA from Leishmania tarentolae. Gene (1984) 1.36
Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases. Lancet (1968) 1.36
Explaining oropharyngeal dysphagia after unilateral hemispheric stroke. Lancet (1997) 1.36
Phylogenetic characterization of epibiotic bacteria in the accessory nidamental gland and egg capsules of the squid Loligo pealei (Cephalopoda:Loliginidae). Environ Microbiol (2001) 1.31
The effects of cytokines and growth factors on osteoblastic cells. Bone (1995) 1.28
Doctors' and nurses' perceptions of ethical problems in end-of-life decisions. J Adv Nurs (2001) 1.28
Lymphocyte transformation using whole blood cultures: an analysis of responses. J Immunol Methods (1972) 1.26
Extended preservation of non-heart-beating donor livers with normothermic machine perfusion. Br J Surg (2002) 1.25
BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Br J Cancer (2012) 1.24
The calibration of a whole-body radioactivity counter for the measurement of body potassium content in clinical studies. Clin Sci (1967) 1.24
A technique for rapid isolation of macrophages from guinea-pig peritoneal exudates. J Clin Pathol (1970) 1.21
Lymphocyte sensitivity to encephalitogenic factor in guinea pigs with experimental allergic encephalomyelitis as shown by in vitro inhibition of macrophage migration. Int Arch Allergy Appl Immunol (1968) 1.21
Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer. Cancer (1972) 1.19
Specific inhibitory action of polyunsaturated fatty acids on lymphocyte transformation induced by PHA and PPD. Int Arch Allergy Appl Immunol (1975) 1.18
Comparison of the traditional paper visual analogue scale questionnaire with an Apple Newton electronic appetite rating system (EARS) in free living subjects feeding ad libitum. Eur J Clin Nutr (1998) 1.18
Macrophages in tissues and in vitro. Curr Opin Immunol (1992) 1.17
Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. Cancer Res (1987) 1.16
On the mode of action of antilymphocytic serum: experiments on electrophoretic mobility of macrophages in experimental allergic encephalomyelitis. Clin Exp Immunol (1970) 1.15
Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection. Br J Cancer Suppl (1973) 1.15
Growth and translation elongation rate are sensitive to the concentration of EF-Tu. Mol Microbiol (1993) 1.15
Diversifying microbial natural products for drug discovery. Appl Microbiol Biotechnol (2003) 1.13
In-vitro inhibition by unsaturated fatty acids of the PPD- and PHA-induced lymphocyte response. Klin Wochenschr (1974) 1.13
Anti-macrophage component of antilymphocytic serum. Lancet (1969) 1.12
The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders. Health Technol Assess (2012) 1.12
Fusidic acid-resistant EF-G perturbs the accumulation of ppGpp. Mol Microbiol (2000) 1.12
Econometric analyses of national health expenditures: can positive economics help to answer normative questions? Health Econ (1993) 1.12
Mutant ribosomes can generate dominant kirromycin resistance. J Bacteriol (1991) 1.11
Lymphocyte sensitivity in cancer. Br Med J (1971) 1.09
Chromosomal assignment of c-MEL, a human transforming oncogene, to chromosome 19 (p13.2-q13.2). Somat Cell Mol Genet (1986) 1.09
A single amino acid substitution in elongation factor Tu disrupts interaction between the ternary complex and the ribosome. J Bacteriol (1993) 1.09
Toxicity of motor neurone disease serum for myelin in tissue culture. Br Med J (1965) 1.09
Stressful life events and the onset of a generalized anxiety syndrome. Am J Psychiatry (1987) 1.07
The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants. J Mol Biol (1996) 1.07
A new mutation in 16S rRNA of Escherichia coli conferring spectinomycin resistance. Nucleic Acids Res (1995) 1.07
Therapeutic results obtained in vaginal mycoses after single-dose treatment with 500 mg clotrimazole vaginal tablets. Am J Obstet Gynecol (1985) 1.03
Discrepancies between whole-body potassium content and exchangeable potassium. J Lab Clin Med (1968) 1.03
A qualitative study of paramedics' attitudes to providing prehospital thrombolysis. Emerg Med J (2005) 1.03
Effect of prazosin vs placebo on chronic left ventricular heart failure. Circulation (1979) 1.02
Macrophage migration inhibition test: a critical examination of the technique using a polythene capillary tubing micromethod. J Immunol Methods (1972) 1.02
Mode of action of antilymphocyte serum. Lancet (1969) 1.02
RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. Leukemia (1988) 1.01
Regulation and role of REST and REST4 variants in modulation of gene expression in in vivo and in vitro in epilepsy models. Neurobiol Dis (2006) 1.01
Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data. Aliment Pharmacol Ther (2009) 1.01
Non-specificity of laboratory test for diagnosis of multiple sclerosis. Br Med J (1974) 0.99
Clinical studies on whole-body potassium content measured by gamma-ray spectrometry in health and disease. Clin Sci (1967) 0.99
Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. J Neurocytol (1994) 0.98
The effect of oxygen on sleep, blood gases, and ventilation in cystic fibrosis. Am Rev Respir Dis (1984) 0.98
Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis. Thorax (2000) 0.98
Randomized trial of bolus phenylephrine or ephedrine for maintenance of arterial pressure during spinal anaesthesia for Caesarean section. Br J Anaesth (1996) 0.97
Suppression of rpsL phenotypes by tuf mutations reveals a unique relationship between translation elongation and growth rate. Mol Microbiol (1993) 0.97
Combined spinal-epidural versus epidural analgesia in labour. Cochrane Database Syst Rev (2007) 0.97
Interprofessional relations between doctors and nurses: perspectives from South Wales. J Adv Nurs (2000) 0.96
A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. Am J Transplant (2006) 0.95
Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val-->Ile. Hum Mol Genet (1992) 0.95
Screening for tuberculosis in an east London HIV clinic. Int J STD AIDS (1995) 0.95
Morphometric analysis of the developing mouse soleus muscle. Am J Anat (1988) 0.95